128 results
Page 2 of 7
8-K
EX-10.1
4v2acjtmu 51660c9mo
23 Nov 22
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.2
ztxm bl9qw5q6tbfwyk2
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
99ztgf
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
EX-10.1
llxbycs8b2rrbh0 i0b4
20 Jul 22
Entry into a Material Definitive Agreement
7:01pm
8-K
EX-10.1
jjk86r6
17 Jun 22
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.2
s70i3yo
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
j8gdy3
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
0br3ov4g 10
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.2
li4g1s6t go4
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-10.1
lpryxe 0wyc9dpvi2
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
r8swsz1uoyn nwidw
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
EX-10.1
wuqeoc0y0vt
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am